文献速递呼吸道感染

ENO Breathe在线呼吸与健康计划对新冠后持续症状患者的影响:一项平行组、单盲、随机对照试验

An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial.
PubMed 文献 · Lancet Respir Med · 2022-04-27

该平行组单盲随机对照试验纳入150例新冠后持续呼吸困难患者,评估6周在线呼吸与健康计划(ENO Breathe)对比常规护理的效果。

要点

  • ENO Breathe可改善新冠后持续症状患者的心理健康复合评分。
  • 该计划对呼吸困难VAS(跑步)有改善作用。
  • 生理健康复合评分及其他次要结局无显著组间差异。

核心结论

  • 在线呼吸与健康计划可改善新冠后持续症状患者HRQoL的心理成分及部分呼吸困难要素。

研究设计与样本

  • 平行组、单盲、随机对照试验,从英国51家长期新冠诊所转诊患者中招募。
  • 纳入158例,排除8例后150例分配至ENO Breathe组(74例)或常规护理组(76例)。
  • ENO Breathe组接受6周在线呼吸与健康计划,聚焦 singing 技术呼吸再训练。
  • 主要结局为RAND 36项短表调查心理健康复合(MHC)和生理健康复合(PHC)评分变化,在意向治疗人群中评估。

主要发现

  • 其他次要结局未见统计学显著组间差异。
  • ENO Breathe组报告1例轻微自限性不良事件(长时间使用电脑感头晕)。

临床怎么用

  • 在线呼吸与健康计划可作为新冠后持续呼吸困难患者支持恢复的辅助手段。
  • 身心和音乐为基础的 approaches 可能有助于症状管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are few evidence-based interventions for long COVID; however, holistic approaches supporting recovery are advocated. We assessed whether an online breathing and wellbeing programme improves health related quality-of-life (HRQoL) in people with persisting breathlessness following COVID-19. METHODS: We conducted a parallel-group, single-blind, randomised controlled trial in patients who had been referred from one of 51 UK-based collaborating long COVID clinics. Eligible participants were aged 18 years or older; were recovering from COVID-19 with ongoing breathlessness, with or without anxiety, at least 4 weeks after symptom onset; had internet access with an appropriate device; and were deemed clinically suitable for participation by one of the collaborating COVID-19 clinics. Following clinical assessment, potential participants were given a unique online portal code. Participants were randomly assigned (1:1) to either immediate participation in the English National Opera (ENO) Breathe programme or to usual care. Randomisation was done by the research team using computer-generated block randomisation lists, with block size 10. The researcher responsible for randomisation was masked to responses. Participants in the ENO Breathe group participated in a 6-week online breathing and wellbeing programme, developed for people with long COVID experiencing breathlessness, focusing on breathing retraining using singing techniques. Those in the deferred group received usual care until they exited the trial. The primary outcome, assessed in the intention-to-treat population, was change in HRQoL, assessed using the RAND 36-item short form survey instrument mental health composite (MHC) and physical health composite (PHC) scores. Secondary outcome measures were the chronic obstructive pulmonary disease assessment test score, visual analogue scales (VAS) for breathlessness, and scores on the dyspnoea-12, the generalised anxiety disorder 7-item scale, and the short form-6D. A thematic analysis exploring participant experience was also conducted using qualitative data from focus groups, survey responses, and email correspondence. This trial is registered with ClinicalTrials.gov, NCT04830033. FINDINGS: Between April 22 and May 25, 2021, 158 participants were recruited and randomly assigned. Of these, eight (5%) individuals were excluded and 150 participants were allocated to a treatment group (74 in the ENO Breathe group and 76 in the usual care group). Compared with usual care, ENO Breathe was associated with an improvement in MHC score (regression coefficient 2·42 [95% CI 0·03 to 4·80]; p=0·047), but not PHC score (0·60 [-1·33 to 2·52]; p=0·54). VAS for breathlessness (running) favoured ENO Breathe participation (-10·48 [-17·23 to -3·73]; p=0·0026). No other statistically significant between-group differences in secondary outcomes were observed. One minor self-limiting adverse event was reported by a participant in the ENO Breathe group who felt dizzy using a computer for extended periods. Thematic analysis of ENO Breathe participant experience identified three key themes: (1) improvements in symptoms; (2) feeling that the programme was complementary to standard care; and (3) the particular suitability of singing and music to address their needs. INTERPRETATION: Our findings suggest that an online breathing and wellbeing programme can improve the mental component of HRQoL and elements of breathlessness in people with persisting symptoms after COVID-19. Mind-body and music-based approaches, including practical, enjoyable, symptom-management techniques might have a role supporting recovery. FUNDING: Imperial College London.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Philip KEJ, Owles H, McVey S, et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir Med. 2022. PMID: 35489367. doi:10.1016/S2213-2600(22)00125-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。